Skip to main content
Year archive

ALTERITY THERAPEUTICS LIMITED — 2022 filings

All 113 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2022, sourced directly from the official regulator.

113 Filings
2022 Period
2022 filings (113)
Filing Released Lang
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-12-29 English
New US patent for compounds to treat neurodegeneration 3 pages 206.1KB
Regulatory Filings
2022-12-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Director's Dealing
2022-12-15 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-12-15 English
Notification of cessation of securities - ATH 4 pages 24.3KB
Share Issue/Capital Change
2022-12-14 English
Change of Director's Interest Notice x 4 8 pages 302.3KB
Director's Dealing
2022-12-14 English
Change in substantial holding 6 pages 1.6MB
Major Shareholding Notification
2022-12-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-11-16 English
ATH Constitution (amended) 50 pages 460.9KB
Governance Information
2022-11-15 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information
2022-11-14 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information
2022-11-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-11-14 English
ATH Annual General Meeting Presentation 31 pages 2.4MB
Regulatory Filings
2022-11-10 English
Chairman's Address 2022 Annual General Meeting 3 pages 324.2KB
AGM Information
2022-11-10 English
Results of Annual General Meeting 2 pages 247.6KB
Declaration of Voting Results & Voting Rights Announcements
2022-11-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-11-07 English
Presentation of bioMUSE urinary symptom profile data 3 pages 207.8KB
Investor Presentation
2022-11-06 English
Change in substantial holding 6 pages 1.6MB
Major Shareholding Notification
2022-11-03 English
SC 13D/A
Major Shareholding Notification
2022-10-31 English
Change in substantial holding 4 pages 131.5KB
Major Shareholding Notification
2022-10-31 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q1 2023
2022-10-28 English
Appendix 4C and Quarterly Cash Flow Report 9 pages 680.0KB
Interim / Quarterly Report Q1 2023
2022-10-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-10-26 English
Presentation of bioMUSE MRI data 3 pages 206.2KB
Regulatory Filings
2022-10-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-10-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-10-13 English
Notice of Annual General Meeting/Proxy Form 22 pages 624.8KB
AGM Information
2022-10-12 English
ATH434 Clinical Trial launched in Australia 3 pages 229.8KB
Regulatory Filings
2022-10-12 English
Change in substantial holding 6 pages 1.6MB
Major Shareholding Notification
2022-09-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-26 English
Wearable Sensor Data from bioMUSE Natural History Study 4 pages 284.4KB
Investor Presentation
2022-09-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-23 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-23 English
Application for quotation of securities - ATH 6 pages 27.7KB
Share Issue/Capital Change
2022-09-22 English
Notice Under Section 708A 1 page 113.4KB
Share Issue/Capital Change
2022-09-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-21 English
Proposed issue of securities - ATH 5 pages 27.3KB
Capital/Financing Update
2022-09-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-20 English
US FDA Approval for IND Application for ATH434 for MSA 3 pages 220.8KB
Regulatory Filings
2022-09-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-09-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Governance Information
2022-08-31 English
ANNUAL REPORT
Annual Report FY 2022
2022-08-31 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-08-31 English
Alterity Form 20-F and XBRL data filed with SEC 2 pages 208.3KB
Report Publication Announcement
2022-08-31 English
Appendix 4E & Annual Report 2022 150 pages 1.8MB
Annual Report FY 2022
2022-08-30 English
Appendix 4G and Corporate Governance Statement 2022 22 pages 396.9KB
Governance Information
2022-08-30 English
SC 13D/A
Major Shareholding Notification
2022-08-26 English
Change in substantial holding 4 pages 359.5KB
Major Shareholding Notification
2022-08-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-08-25 English
ATH434 Phase 2 clinical launched in Europe 3 pages 228.4KB
Regulatory Filings
2022-08-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-08-24 English
Extension to regain NASDAQ minimum bid price compliance 3 pages 203.1KB
Regulatory Filings
2022-08-23 English
SC 13D/A
Major Shareholding Notification
2022-08-01 English
Change in substantial holding 4 pages 308.5KB
Major Shareholding Notification
2022-08-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q4 2022
2022-07-22 English
Appendix 4C and Quarterly Cash Flow Report 9 pages 689.5KB
Interim / Quarterly Report Q4 2022
2022-07-21 English
SC 13D/A
Major Shareholding Notification
2022-07-20 English
Change in substantial holding 4 pages 194.6KB
Major Shareholding Notification
2022-07-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-07-06 English
First Patient dosed in ATH434 Phase 2 Clinical Trial 3 pages 209.4KB
Regulatory Filings
2022-07-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-30 English
Alterity receives a $4.1 million R&D Tax Refund 1 p
Capital/Financing Update
2022-06-29 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-27 English
Notification of cessation of securities - ATH 4 pages 24.3KB
Share Issue/Capital Change
2022-06-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-23 English
Regulatory Approval to Proceed with Phase 2 Trial in Italy 3 pages 207.5KB
Regulatory Filings
2022-06-22 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-21 English
Alterity to Present at Life Sciences Investor Forum 2 pages 142.8KB
Investor Presentation
2022-06-19 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-14 English
Alterity to present at GCFF Virtual Conference 2022 1
Investor Presentation
2022-06-13 English
AMENDMENT NO.1 TO FROM 6-K
Regulatory Filings
2022-06-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-06-02 English
Alterity Launches ATH434 Phase 2 Clinical Trial 3 pages 256.3KB
Regulatory Filings
2022-06-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-05-26 English
Alterity to Participate in the Benchmark Company Conference 1
Regulatory Filings
2022-05-25 English
Change in substantial holding 5 pages 871.9KB
Major Shareholding Notification
2022-05-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q3 2022
2022-05-02 English
Appendix 4C and Quarterly Cash Flow Report 9 pages 1.5MB
Interim / Quarterly Report Q3 2022
2022-04-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-04-27 English
UK Regulatory Authorisation to Proceed with Phase 2 Trial 3 pages 233.4KB
Regulatory Filings
2022-04-26 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-04-07 English
Presentation of bioMUSE Data at the AAN Annual Meeting 4 pages 263.1KB
Investor Presentation
2022-04-06 English
SC 13D/A
Major Shareholding Notification
2022-03-28 English
Change in substantial holding 9 pages 3.2MB
Regulatory Filings
2022-03-21 English
Change in substantial holding 5 pages 846.2KB
Major Shareholding Notification
2022-03-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-03-15 English
Alterity to participate in Sachs Neuroscience Conference 1
Regulatory Filings
2022-03-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-03-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-03-07 English
Alterity to Present at the 34th Annual Roth Conference 1
Investor Presentation
2022-03-06 English
Investor Presentation 32 pages 5.2MB
Regulatory Filings
2022-03-06 English
SC 13D/A
Major Shareholding Notification
2022-03-04 English
NASDAQ Non-Compliance Notice Received 2 pages 226.2KB
Regulatory Filings
2022-02-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report H1 2022
2022-02-28 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-02-28 English
Half Yearly Report and Accounts 27 pages 398.1KB
Interim / Quarterly Report H1 2022
2022-02-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-01-28 English
New publication shows ATH434 rescues neurons in MSA model 3 pages 278.9KB
Regulatory Filings
2022-01-27 English
REPORT OF FOREIGN PRIVATE ISSUER
Interim / Quarterly Report Q2 2022
2022-01-27 English
Appendix 4C and Quarterly Cash Flow Report 8 pages 432.9KB
Interim / Quarterly Report Q2 2022
2022-01-26 English
Change in substantial holding 5 pages 870.2KB
Major Shareholding Notification
2022-01-23 English
Response to ASX Query 5 pages 224.7KB
Regulatory Filings
2022-01-12 English
Change in substantial holding 5 pages 907.0KB
Major Shareholding Notification
2022-01-06 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-01-06 English
New US Patent for Compounds to Treat Neurodegeneration 3 pages 271.2KB
Regulatory Filings
2022-01-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-01-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Director's Dealing
2022-01-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2022-01-05 English
Notification of cessation of securities - ATH 4 pages 24.3KB
Share Issue/Capital Change
2022-01-04 English
Final Director's Interest Notice x 2 4 pages 290.5KB
Director's Dealing
2022-01-04 English
Alterity to present at H.C. Wainwright Conference 2 pages 203.0KB
Investor Presentation
2022-01-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Board/Management Information
2022-01-04 English
Alterity announces resignation of Non-Executive Directors 2 pages 188.8KB
Board/Management Information
2022-01-03 English